AMLX fundamentals
An in-depth look to Amylyx Pharmaceuticals, Inc. operating, investing, and financing activities
AMLX free cash flow for Q3 24 is -41.55 M USD. For 2023, AMLX free cash flow was 10.68 M USD and operating cash flow was 11.92 M USD.
Q4 '20
Q1 '21
Q2 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '20
Q1 '21
Q2 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM